• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/66

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

66 Cards in this Set

  • Front
  • Back
OSMOSIS
A MOLOCULE MOVING ACROSS A MEMBRANE
PHARMOKENETICS
THE STUDY OF HOW A DRUG ENTERS, MOVES THROUGH, AND EXITS THE BODY
PHARMODYNAMICS

THE STUDY OF A DRUGS EFFECTS ON A BODY
ASSAY

INVESTIGATIVE PROCEDURE FOR QUALITY ASSURANCE OFQUANITIVE MEASUREMENT, OR FUNCTIONAL ACTIVITY OF A DRUG
BIOEQUIVALENCE


TWO PROPRIATARY PREPERATIONS OF A DRUG THAT ARE THE SAME.




I.E. CIALIS , VIAGRA

BIOASSAY

EXPERIMENT ON LIVE SUBJECT TO DETERMINE BIOLOGIC ACTIVITY OF A DRUG
TERATOGENIC

AGENT (DRUG) THAT CAN CAUSE A BIRTH DEFECT

THERAPEUDIC INDEX

DRUGS DESIRED DOSE VS. DRUG TOXCICITY AMOUNT

LETHAL DOSE

DOSE, USUALY IN DOSE PER kg. THAT WILL BE FATAL

EFFECTIVE DOSE

DOSE THAT PRODUCES A THERAPEUDIC RESPONCE

SECOND MESSENGER

MOLOCULES THAT RELAY SIGNALS RECIEVED AT THE RECEPTORS ON THE CELL LEVEL

DIFFUSION

MOLOCULES INTERMINGLEING
FILTRATION

SEPARATION OF SOLIDS FROM LIQUIDS
BIOAVALIBILITY


THE FRACTION OF A DOSE THAT REACHES SYSTEMIC CIRCULATION




I.E. I.V. FLUIDS WILL HAVE A BIOAVALIBILITY OF 100%


BLOOD BRAIN BARRIER

MEMBRANE SEPARATING BLOOD FROM BRAIN EXTRACELLULAR FLUID

PLACENTAL BARRIER

MEMBRANE SEPARATING MATERNAL BLOOD FROM FETAL BLOOD

METABOLISIM

ALL CHEMICAL REACTIONS INVOLVED IN MAINTAINING THE STATE OF A CELL AND THE ORGANISIM

BIOTRANSFORMATION

WHEN A SUBSTANCE IS CHANGED FROM ONE CHEMICLE TO ANOTHER BY A CHEMICAL REACTION

FIRST PASS EFFECT

PHENOMENON BY WHICH A DRUG IS GREATLY REDUCED BEFORE IT REACHES SYSTEMIC CIRCULATION
RECEPTOR

ORGAN OR CELL ABLE TO RESPOND TO LIGHT HEAT OR OTHER EXTERNAL SOURCES AND TRANSMIT A SIGNAL

AFFINITY

ABILITY OF A DRUG TO BIND TO ITS BIOLOGICAL AGENT

EFFICACY

CAPACITY FOR THERAPEUDIC EFFECT OF A GIVEN INTERVENTION
AGONIST

CHEMICAL THAT BINDS TO A RECEPTOR AND ACTIVATES IT TO PRODUCE A BIOLOGIC RESPONSE
ANTAGONIST

CHEMICAL THAT BINDS TO A RECEPTOR AND CANNOT ACTIVATE IT

AGONIST-ANTAGONIST

HAS PROPERTIES OF BOTH AN AGONIST AND AN ANTAGONIST

ONSET OF ACTION

DURATION OF TIME FOR A DRUGS EFFECTS TO COME TO PROMONINCE UPON ADMINISTRATION

DURATION OF ACTION

LENGTH OF TIME A DRUG IS EFFECTIVE

BIOLOGIC HALF-LIFE

TIME IT TAKES A DRUG TO LOSE HALF OF ITS PHARMAOLOGIC ACTIVITY

MEDICATION CONCENTRATION


AMOUNT OF DRUG IN A GIVIN VOLUME OF PLASMA




I.E. mg/ml




ISOTONIC SOLUTIONS

MOVEMENT OF WATER OUT OF A CELL IS BALANCED BY WATER MOVING IN




I.E. ANIMALS CELLS ARE IN I.S. WITH .09% NaCl (NORMAL SALINE)

PURE FOOD AND DRUG ACT 1906

IMPROVE QUALITY AND LABELING OF DRUGS NAMED UNITED STATES PHARMOCOPEA (USP)


AS THE COUNTRIES OFFICIAL SOURCE FOR DRUG INFORMATION

HARRISON NARCOTIC ACT 1914

LIMITED USE OF ADDICTING DRUGS BY REGULATING IMPORTATION MANUF. AND SALE AND USE OF OPIUM COCAINE AND THEIR COMPOUNDS

FEDERAL FOOD DRUG AND COSMETIC ACT 1938
EMPOWERED FDA TO ENFORCE AND SET PREMARKET SAFETY STANDARDS FOR DRUGS
DURHAM-HUMPHERY AMENDMENTS


(PRESCRIPTION DRUG AMENDMENTS)


REQUIRES PHARMASISTS TO HAVE WRITTEN OR ORAL PRESCRIPTIONS FROM A PHYSICIAN TO DISPENCE CERTAIN DRUGS

KEFAUVER HARRIS AMENDMENT 1962

REQUIRED MAUNFACTURERS TO PROVIDE PROOF SAFETY AND EFFECTIVENESS OF THEIR DRUGS BEFOR EBEING GRANTED PERMISSION TO PRODUCE AND MARKET PRODUCTS
COMPREHENSIVE DRUG ABUSE AND PREVENTION ACT 1970
(CONTROLLED SUBSTANCE ACT) REPLACED HARRISON ACT AND CREATED 5 SCHEDULES OF CONTOLLED SUBSTANCES
DRUG SOURCES


I.E. PHYSICIANS DESK REFERANCE


DRUGS.COM


WEBMD


SKYSCAPE


MEDIMATH


USP


DRUG SOURCES (4 TYPES)

PLANT-MORPHINE, ATROPINE,


ANIMAL- INSULIN, OXYTOCIN


MINERAL- SODIUM BICARB, CALCIUM CHLORIDE


SYNTHETIC- ADENOSINE, DIAZEPAM,HEP B VACC.

DRUG STORAGE

KEEP DRUGHS IN A LOCKED SAFE OR BOX ON THE UNIT PER FEDERAL LAW, IF MEDS ARE IN A JUMP BAG MUST BE SEALED WITH TAMPER RESISTANT SEAL

ETERAL DRUG ROUTE
DRUGS ABSORBED BY G.I. TRACT
PARENTRAL

LIQUID MEDICATION GIVEN BY I.V. I.M. OR SUB Q.

SIX RIGHTS TO MEDICATION ADMINISTRATION


RIGHT PT.


RIGHT MED


RIGHT ROUTE


RIGHT DOSE


RIGHT TIME


RIGHT DOCUMENTATION

ORAL

30-45 MIN MOST CONVINIENT
SUBLINGUIL

MUCOSSA UNDER TOUNGE VERY VASCULAR
BUCCCAL

MUCOSSA BETWEEN CHEEK AND GUM
SCHEDULE I DRUG


SCHEDULE I HIGHLY DEPENDANT, HIGH ABUSE POTENTIAL NO MEDICAL INDICATIONS ONLY RESEARCH, ANAYLISIS, OR INSTRUCTION.


I.E. HEROIN, LSD

SCHEDULE II DRUG


HIGH ABUSE POTENTIAL MAY LEAD TO SEVERE DEPENDANCE, ACCEPTED MEDICAL INDICATIONS


I.E. OPIUM, OXYCODINE, COCAINE, METHADONE, MORPHINE

SCHEDULE III DRUG


LESS ABUSE POTENTIAL THAN SCHEDULE I, II, ACCEPTED MEDICAL INDICATIONS




I.E. VICODIN, TYLENOL WITH CODINE, LIMITED OPIOID AMOUNTS OR COMBINED WITH OTHER NON CONTROLLED SUBSTANCES

DRUG FORMS

SOLIDS; POWDERS,TABLETS,SUPPOSITORIES


LIQUIDS; SOLUTIONS,TINCTURES,


INHALANTS

SIMPLEST FORM OF B.S.I.


HANDWASHING
PHASE I FDA APPROVAL

DETERMINE DRUGS PHARMOKINETICS, TOXCICITY, AND SAFE DOSE IN HUMANS

PHASE II FDA APPROVAL

TESTED ON A LIMITED POPULATION OF PTS WHO HAVE THE DISEASE INTENDED TO BE TREATED BY THE MEDICATION, FIND THERAPUDIC LEVEL AND WATCH FOR TOXIC EFFECTS

PHASE III FDA APPROVAL


REFINE THERAPEUDIC DOSE AND COLLECT RELEVANT DADA, ON LARGE POPULATIONS OF PTS.


I.E. DOUBLE BLIND STUDIES AND CONTROLLED STUDIES


ABLE TO APPLY FOR NEW DRUG APPLICATION AFTER COMPLETION

PHASE IV FDA APPROVAL

POSTMARKETING ANALYISIS DURING CONDITIONAL APPROVAL
8 FACTORS ALTERING DRUG RESPONSE

AGE


BODY MASS


SEX


ENVIROMENTAL MILIEU (MOOD AND ENVIROMENT)


TIME OF ADMINISTRATION


PATHOLOGICAL STATE


GENETIC FACTORS


PSYCHOLOGICAL FACTORS

IDIOSYCRASY

DRUG EFFECT THAT IS UNIQUE TO THE INDIVIDUAL

CROSS TOLLERANCE


TOLERANCE FOR A DRUG THAT DEVELOPS AFTER ADMINISTRATION OF A DIFFERENT DRUG


I.E. MORPHINE AND OPIOIDS


ALLERGIC REACTION

ALSO REFERED TO AS HYPERSENSITIVITY, ACTIVATES IMMUNE SYSTEM

SYNERGISIM

TWO DRUGS TAT HAVE THE SAME EFFECT THAT ARE GIVEN TOGETHER AND PRODUCE A RESPONCE GREATER THAN THE SUM OF THEIR INDIVIDUAL RESPONSES. 1+1=3
PASSIVE TRANSPORT

THE MOVEMENT OF A SUBSTANCE WITHOUT THE USE OF ENERGY
FACILITATED TRANSPORT

THE MOVEMENT OF A SUBSTANCE WITH THE USE OF ENERGY
NON COMPETITIVE ANTAGONISIM

OCCURS BECAUSE THE BINDING OF THE ANTAGONIST AT A DIFFERENT SITE CAUSES A DEFORMITY AND PREVENTS THE AGONIST FROM FITTING AND BINDING

POTENTIATION

ENHANCEMENT OF ONE AGENT BY ANOTHER SO THE COMBINED EFECT IS GREATER THAN THAT OF ONE AGENT ALONE
ELIMINATION

PROCESS OF EXERTION OF AN AGENT BY ANY ONE NUMBER OF PROCESSES BY WHICH A DRUG IS ELIMINATED
ADVERSE REACTION

ANY UNEXPECTED OR DANGEROUS REACTION TO A DRUG

ABSORBTION

IS THE PROCESS OF MOVEMENT OF A MEDICATION FROM THE SITE OF APPLICATION TO THE EXTRACELLULAR COMPARTMENT.